A detailed history of Great Lakes Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 1,109,183 shares of ABT stock, worth $131 Million. This represents 1.14% of its overall portfolio holdings.

Number of Shares
1,109,183
Previous 1,101,278 0.72%
Holding current value
$131 Million
Previous $114 Million 10.51%
% of portfolio
1.14%
Previous 1.08%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$100.07 - $118.13 $791,053 - $933,817
7,905 Added 0.72%
1,109,183 $126 Million
Q2 2024

Aug 05, 2024

SELL
$100.73 - $112.44 $5.5 Million - $6.14 Million
-54,572 Reduced 4.72%
1,101,278 $114 Million
Q1 2024

May 08, 2024

BUY
$109.52 - $120.96 $3.78 Million - $4.18 Million
34,541 Added 3.08%
1,155,850 $131 Million
Q4 2023

Feb 08, 2024

SELL
$90.19 - $110.4 $17.6 Million - $21.5 Million
-194,816 Reduced 14.8%
1,121,309 $123 Million
Q3 2023

Nov 07, 2023

BUY
$95.53 - $114.62 $118 Million - $142 Million
1,237,313 Added 1569.96%
1,316,125 $127 Million
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $97.1 Million - $108 Million
-963,548 Reduced 92.44%
78,812 $8.59 Million
Q1 2023

May 10, 2023

BUY
$96.86 - $114.01 $96.5 Million - $114 Million
995,969 Added 2146.9%
1,042,360 $106 Million
Q4 2022

Feb 09, 2023

SELL
$95.06 - $111.52 $115,022 - $134,939
-1,210 Reduced 2.54%
46,391 $5.09 Million
Q3 2022

Nov 09, 2022

BUY
$96.76 - $112.03 $122,691 - $142,054
1,268 Added 2.74%
47,601 $4.61 Million
Q2 2022

Aug 09, 2022

BUY
$102.07 - $123.37 $125,137 - $151,251
1,226 Added 2.72%
46,333 $5.03 Million
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $1.44 Million - $1.76 Million
-12,658 Reduced 21.91%
45,107 $5.34 Million
Q4 2021

Feb 09, 2022

BUY
$115.53 - $141.46 $1.49 Million - $1.82 Million
12,865 Added 28.65%
57,765 $8.13 Million
Q3 2021

Nov 09, 2021

SELL
$116.66 - $129.06 $185,139 - $204,818
-1,587 Reduced 3.41%
44,900 $5.3 Million
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $87,170 - $102,612
824 Added 1.8%
46,487 $5.39 Million
Q1 2021

May 03, 2021

BUY
$108.84 - $128.23 $32,652 - $38,469
300 Added 0.66%
45,663 $5.47 Million
Q4 2020

Feb 09, 2021

BUY
$105.0 - $114.42 $30,240 - $32,952
288 Added 0.64%
45,363 $4.97 Million
Q3 2020

Nov 04, 2020

BUY
$91.64 - $111.29 $55,900 - $67,886
610 Added 1.37%
45,075 $4.91 Million
Q2 2020

Aug 07, 2020

SELL
$76.57 - $98.0 $53,828 - $68,894
-703 Reduced 1.56%
44,465 $4.07 Million
Q1 2020

May 08, 2020

SELL
$62.82 - $91.86 $53,208 - $77,805
-847 Reduced 1.84%
45,168 $3.56 Million
Q4 2019

Feb 07, 2020

SELL
$78.51 - $87.4 $570,139 - $634,698
-7,262 Reduced 13.63%
46,015 $4 Million
Q3 2019

Nov 06, 2019

SELL
$81.84 - $88.74 $244,128 - $264,711
-2,983 Reduced 5.3%
53,277 $4.46 Million
Q2 2019

Aug 05, 2019

SELL
$72.88 - $85.0 $661,677 - $771,715
-9,079 Reduced 13.9%
56,260 $4.73 Million
Q1 2019

May 07, 2019

SELL
$66.22 - $80.06 $32.8 Million - $39.7 Million
-495,693 Reduced 88.35%
65,339 $5.22 Million
Q4 2018

Feb 13, 2019

SELL
$65.56 - $74.27 $18.1 Million - $20.5 Million
-275,573 Reduced 32.94%
561,032 $40.6 Million
Q3 2018

Nov 30, 2018

BUY
$60.81 - $73.36 $50 Million - $60.3 Million
822,079 Added 5659.36%
836,605 $61.4 Million
Q3 2018

Nov 15, 2018

SELL
$60.81 - $73.36 $46.8 Million - $56.4 Million
-769,202 Reduced 98.15%
14,526 $1.07 Million
Q2 2018

Aug 13, 2018

SELL
$57.57 - $63.54 $24.1 Million - $26.6 Million
-418,277 Reduced 34.8%
783,728 $47.8 Million
Q1 2018

May 07, 2018

SELL
$56.27 - $63.62 $2.17 Million - $2.46 Million
-38,645 Reduced 3.11%
1,202,005 $64.7 Million
Q4 2017

Feb 08, 2018

SELL
$53.68 - $57.47 $3.17 Million - $3.39 Million
-59,053 Reduced 4.54%
1,240,650 $70.8 Million
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $62.5 Million - $69.7 Million
1,299,703
1,299,703 $69.4 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $206B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.